Pan-European drug discovery platform launched
The European Lead Factory, a novel platform for innovative drug discovery, was recently launched by an international consortium of 30 partners, including AstraZeneca.
Find out more about Open Innovation on LabTalk
Read the press release
CytImmune collaboration into nanomedince for cancer treatment
CytImmune and AstraZeneca entered into an agreement in December to study the feasibility of a new cancer nanomedicine that will bind an oncology compound from AstraZeneca to CytImmune’s CYT-6091 nanomedicine platform.
Find out more on LabTalk
Read the press release
Scrip Roundtable: Preventing a Pre-antibiotic Future
In June, AstraZeneca took part in a moderated roundtable discussion exploring the increasing resistance of bacteria and the research and use of antibiotics.
Watch the discussion in full
Watch the highlights video
